MX2015009829A - Composiciones de mentol liquidas. - Google Patents
Composiciones de mentol liquidas.Info
- Publication number
- MX2015009829A MX2015009829A MX2015009829A MX2015009829A MX2015009829A MX 2015009829 A MX2015009829 A MX 2015009829A MX 2015009829 A MX2015009829 A MX 2015009829A MX 2015009829 A MX2015009829 A MX 2015009829A MX 2015009829 A MX2015009829 A MX 2015009829A
- Authority
- MX
- Mexico
- Prior art keywords
- menthol
- composition
- oil
- edible oil
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Edible Oils And Fats (AREA)
Abstract
Se proporciona una composición que comprende: (i) mentol y (ii) un portador que comprende un aceite comestible digerible, en donde el aceite comestible digerible es uno que proporciona una composición que es un líquido a 20°C después de la elevación a esa temperatura desde una temperatura menor en la cual el aceite estuvo previamente semisólido. El aceite comestible preferido es un aceite de triglicérido de cadena mediana, en donde el nivel de mentol en la composición está entre 1-50% en peso total, para proporcionar una proporción de aplicación de mentol de entre 5 y 20 mg de mentol, y mucho más de preferencia, aproximadamente 10 mg de mentol, en una sola gotita de la composición. La composición también puede incluir vitaminas agregadas adicionales y aceites esenciales. Se proporciona un método de líquido para administrar mentol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759839P | 2013-02-01 | 2013-02-01 | |
| PCT/CA2014/000090 WO2014117265A1 (en) | 2013-02-01 | 2014-01-31 | Liquid menthol compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015009829A true MX2015009829A (es) | 2016-04-07 |
| MX363963B MX363963B (es) | 2019-04-09 |
Family
ID=51261350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009829A MX363963B (es) | 2013-02-01 | 2014-01-31 | Composiciones de mentol liquidas. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9999602B2 (es) |
| EP (1) | EP2950823B1 (es) |
| JP (1) | JP6552414B2 (es) |
| KR (1) | KR102187731B1 (es) |
| CN (1) | CN105324130A (es) |
| AU (1) | AU2014211953B2 (es) |
| BR (1) | BR112015018275B1 (es) |
| CA (1) | CA2899250C (es) |
| ES (1) | ES2821793T3 (es) |
| MX (1) | MX363963B (es) |
| NZ (1) | NZ710769A (es) |
| PL (1) | PL2950823T3 (es) |
| PT (1) | PT2950823T (es) |
| RU (1) | RU2666997C2 (es) |
| WO (1) | WO2014117265A1 (es) |
| ZA (1) | ZA201505515B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201608943D0 (en) * | 2016-05-20 | 2016-07-06 | British American Tobacco Co | Capsule for tobacco industry product |
| US11305074B2 (en) | 2018-01-25 | 2022-04-19 | Biogastrex Llc | Insufflation system |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| US11622944B2 (en) | 2020-01-31 | 2023-04-11 | Babak Ghalili | Stabilized menthol and other volatile compound compositions and methods |
| US20230133580A1 (en) | 2020-03-30 | 2023-05-04 | Sunsho Pharmaceutical Co., Ltd. | Menthol-containing composition |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL106578A (en) * | 1993-08-03 | 2000-08-13 | Yissum Res Dev Co | Pharmaceutical compositions for drug targeting |
| AU3440697A (en) | 1996-07-02 | 1998-01-21 | Novartis Consumer Health S.A. | Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| WO2000037044A1 (en) | 1998-12-21 | 2000-06-29 | Biovail International Ltd. | Soft and chewy cough and cold relief composition |
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| WO2003097026A1 (fr) * | 2002-05-22 | 2003-11-27 | Nihon Pharmaceutical Co., Ltd. | Inhibiteur du peristaltisme de muscles lisses |
| US7138394B2 (en) * | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| US20060105000A1 (en) * | 2002-11-21 | 2006-05-18 | J.P.M.E.D. Ltd | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
| ES2379876T3 (es) * | 2003-06-30 | 2012-05-04 | Nihon Pharmaceutical Co., Ltd. | Preparación que contiene mentol |
| US20070042007A1 (en) * | 2005-08-19 | 2007-02-22 | Joseph Schwarz | Topical composition for delivery of salicylate esters |
| WO2007115593A1 (en) * | 2006-04-11 | 2007-10-18 | Symrise Gmbh & Co. Kg | Composition of menthyl lactate and a mixture of menthol isomers |
| CA2558202A1 (en) | 2006-09-14 | 2006-11-23 | Reinhold W. Vieth | Vitamin d compositions and method of administration to infants |
| JP2008231049A (ja) * | 2007-03-22 | 2008-10-02 | Saburo Yasuda | アポトーシス誘導物質 |
| CA2711703A1 (en) | 2008-01-08 | 2009-07-16 | Foamix Ltd. | Sensation modifying topical composition foam |
| EP2692252B1 (en) * | 2011-03-31 | 2018-06-06 | Japan Tobacco, Inc. | Cigarette |
| CA2745267C (en) | 2011-07-05 | 2019-09-24 | Reinhold Vieth | Iron supplement composition |
-
2014
- 2014-01-31 EP EP14745596.8A patent/EP2950823B1/en active Active
- 2014-01-31 CA CA2899250A patent/CA2899250C/en active Active
- 2014-01-31 WO PCT/CA2014/000090 patent/WO2014117265A1/en active Application Filing
- 2014-01-31 PT PT147455968T patent/PT2950823T/pt unknown
- 2014-01-31 RU RU2015137043A patent/RU2666997C2/ru active
- 2014-01-31 AU AU2014211953A patent/AU2014211953B2/en active Active
- 2014-01-31 JP JP2015555505A patent/JP6552414B2/ja active Active
- 2014-01-31 KR KR1020157023448A patent/KR102187731B1/ko active Active
- 2014-01-31 NZ NZ710769A patent/NZ710769A/en unknown
- 2014-01-31 ES ES14745596T patent/ES2821793T3/es active Active
- 2014-01-31 US US14/762,730 patent/US9999602B2/en active Active
- 2014-01-31 MX MX2015009829A patent/MX363963B/es active IP Right Grant
- 2014-01-31 CN CN201480019951.1A patent/CN105324130A/zh active Pending
- 2014-01-31 PL PL14745596T patent/PL2950823T3/pl unknown
- 2014-01-31 BR BR112015018275-5A patent/BR112015018275B1/pt active IP Right Grant
-
2015
- 2015-07-31 ZA ZA2015/05515A patent/ZA201505515B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6552414B2 (ja) | 2019-07-31 |
| ES2821793T3 (es) | 2021-04-27 |
| WO2014117265A1 (en) | 2014-08-07 |
| RU2666997C2 (ru) | 2018-09-13 |
| CA2899250C (en) | 2021-11-23 |
| JP2016506934A (ja) | 2016-03-07 |
| BR112015018275A2 (pt) | 2017-07-18 |
| KR20150123813A (ko) | 2015-11-04 |
| US20150359753A1 (en) | 2015-12-17 |
| PL2950823T3 (pl) | 2021-02-08 |
| CA2899250A1 (en) | 2014-08-07 |
| EP2950823B1 (en) | 2020-07-01 |
| EP2950823A1 (en) | 2015-12-09 |
| EP2950823A4 (en) | 2016-10-19 |
| AU2014211953B2 (en) | 2018-08-02 |
| MX363963B (es) | 2019-04-09 |
| RU2015137043A (ru) | 2017-03-10 |
| AU2014211953A1 (en) | 2015-08-20 |
| US9999602B2 (en) | 2018-06-19 |
| CN105324130A (zh) | 2016-02-10 |
| BR112015018275B1 (pt) | 2021-10-19 |
| PT2950823T (pt) | 2020-10-07 |
| ZA201505515B (en) | 2016-10-26 |
| KR102187731B1 (ko) | 2020-12-07 |
| NZ710769A (en) | 2020-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
| PH12016500100A1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| NZ710769A (en) | Liquid menthol compositions | |
| BR112014027719A2 (pt) | método para preparar um gel óleo comestível, gel óleo comestível, uso do gel óleo comestível, produto alimentício e uso de produto alimentício | |
| IN2014DN08088A (es) | ||
| PH12014501929A1 (en) | Food and beverage products containing 1,3-propanediol and methods of modifying flavor release using 1,3-propanediol | |
| BR112014029077A2 (pt) | composições e métodos para aumentar a estabilidade de aditivos para produto alimentar | |
| IN2014DN08254A (es) | ||
| MY189030A (en) | Fats and oils | |
| MX2013014878A (es) | Fluido dielectrico de aceite microbiano geneticamente diseñado. | |
| PH12016501902B1 (en) | Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed | |
| MY173665A (en) | Interesterified oils and fats, and oil based food including the interesterified oils and fats | |
| MX2015013738A (es) | Composicion rodenticida de cebo blando. | |
| MX2016003619A (es) | Composicion de grasa comestible. | |
| NZ720512A (en) | Multi-particulate drug delivery system | |
| AR100028A1 (es) | Composiciones nutricionales que contienen ácido estearidónico | |
| PH12016501901A1 (en) | Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed | |
| SG10201810977XA (en) | Dilute-type nutritional composition | |
| MX374942B (es) | Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia. | |
| RU2013146038A (ru) | Косметическая композиция в виде эмульсии вода-в-масле | |
| NZ603428A (en) | Synergistic composition of galactolipid in combination with ascorbic acid for protection against oxidation | |
| MX2016013680A (es) | Métodos y composiciones para el tratamiento de trastornos por el almacenamiento de lípidos. | |
| MX2016014899A (es) | Proceso para la manufactura de emulsion comestible agua en aceite. | |
| PE20141705A1 (es) | Composicion que confiere aroma y/o sabor, producto alimenticio y metodo de produccion para dicho producto alimenticio | |
| WO2012108745A3 (ko) | 조각인 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |